The Conference


BioData World Congress is the world's leading event for individuals working with Big Data in precision medicine.

The two day conference will feature case study applications of Big Data and Genomics to drive precision medicine into the clinic through the assembly of the multidisciplinary cohort involved in the delivery of the Precision Medicine


The event will cover a range of different topics including:

  • How to manage data generated in bioinformatics
  • How to utilise NGS to develop more targeted therapeutics
  • How to practically apply genomic data in precision medicine
  • Utilizing the Cloud for collaborative research
  • \Developing secure information systems 
  • Ethical considerations in the sharing of genomic data 
  • How to transition big data into the clinic 
  • How to access open source technologies in LS research 
  • How to apply big data analytics to mine information

There will be truly visionary keynotes, panel debates, quality networking breaks, chat show panels, speed networking and roundtable discussions throughout the event.

Presentations will be delivered by:

  • Clinicians and decision makers involved in implementing personalized medicine 
  • Big Pharma who are tailoring their pharmaceutical products in readiness for the revolution 
  • Leaders from major Big Data/Bioinformatics Institutions


We have now confirmed the 2017 congress streams.


  Data Storage & Management

Transforming Big Data into Smart Data 

Data Computing  

Data Discovery & Generation 


Early Confirmed Speakers


  • Andrew Roddam, Vice President & Global Head Epidemiology, GSK 
  • Antonio Criminisi, Principal Researcher, Microsoft Research 
  • Athula Herath, Global Head of RWE Disease Epidemiology, Novartis 
  • Bissan Al Lazikani, Head of Data Science, Institute of Cancer Research 
  • Bronwyn Kerr, Honorary Clinical Professor of Paediatrics and Clinical Genetics, University of Manchester
  • Claus Nielsen, Public Affairs, Data for Good Foundation 
  • David Pearce, President, Sanford Research
  • David Smith, Professor of Laboratory Medicine and Pathology, Mayo Clinic
  • Eerke Boiten, Professor of Cyber Security, De Montfort University
  • Emanuele De Rinaldis, Head of Translational Bioinformatics, NIHR Biomedical Research Centre & Honorary Senior Lecturer, King's College London
  • Ena Wang, Research Chief, Translational Medicine, Sidra Medical and Research Center, Qatar
  • James Weatherall, Executive Director & Head, Advanced Analytics Centre, AstraZeneca
  • Jan Kuentzer, Head of Data Science Application Services, pRED Informatics, Roche Innovation Center Munich 
  • Jean-Louis Mandel, Professor of Human Genetics, Collège de France
  • Jennifer Hall, Chief, Institute for Precision Cardiovascular Medicine, American Heart Association
  • Jo Churchill MP, Chair, APPG on Personalised Medicine
  • John Ainsworth, Director, Connected Health Cities
  • Sir John Burn, Non-executive director, Professor of Clinical Genetics, NHS England & Newcastle University
  • John Wise, Executive Director, Pistoia Alliance
  • Julia Wilson, Associate Director, Wellcome Trust Sanger Institute
  • Lorna Ewart, Head of IMED MPS Centre of Excellence, AstraZeneca
  • Maria Chatzou, Research Bioinformatics Engineer, Center for Genomic Regulation & President, Innovation Forum Barcelona
  • Mathew Woodwark, Director of Research Bioinformatics, MedImmune
  • Matthieu-P. Schapranow, Program Manager E-Health, Hasso Plattner Institute 
  • Natalie Banner, Policy Adviser, Wellcome Trust
  • Patrick Harnett, Consultant Physician and Nephrologist, Southend University Hospital NHS Foundation Trust
  • Pearse Keane, NIHR Clinician Scientist and Honorary Consultant Ophthalmologist, Moorfields Eye Hospital NHS Foundation Trust 
  • Peter Frommolt, Head of Bioinformatics Facility, University Of Cologne
  • Philip Quinlan, Director, UKCRC Tissue Directory and Coordination Centre
  • Philippe Sanseau, Head Computational Biology and Stats, GSK
  • Radouane Oudrhiri, Chief Data Scientist, Eagle Genomics
  • Rebecca Lumsden, Head of Science Policy, ABPI
  • Richard Scott, Clinical Lead for 100,000 Genomes Project Rare Disease, Genomics England
  • Ruth March, Vice President and Head of Personalized Healthcare and Biomarkers, AstraZeneca
  • Serena Scollen, Head of Human Genomics and Translational Data, ELIXIR
  • Sharmini Alagaratnam, Principal Researcher, BigMed (DNV GL Research)
  • Stuart Bayliss, Business Support Manager, Manchester Centre for Genomic Medicine
  • Timothy Stitt, Head of Scientific Computing, Earlham Institute
  • Tony Whetton, Director, Stoller Biomarker Discovery Centre 





Get involved

If you’d like to become an exhibitor, sponsor or speaker at the event
contact Alistair Wilmot  at
or +44 (0)20 7092 1174